Here are 17 key notes on spine and orthopedic device companies.
The European Patent Office will soon grant a key patent for the core technology of aap Implantate's LOQTEQ locking and compression plate system.
Amedica is taking a comprehensive business review to heart, and will reduce its staff by 28 percent.
Bacterin reported their fourth quarter and total year preliminary financial results for 2014, including an 8 percent to 10 percent increase in 4Q revenue over the same period last year.
BioElectronics appointed B. Braun Medical as the exclusive U.K. distributor of its RecoveryRx pain device.
Cerapedics received the CE Mark in Europe and Therapeutic Goods Administration listing in Australia for its new i-FACTOR Flex FR biologic bone graft.
Integra LifeSciences closed its acquisition of Metasurg's product portfolio.
K2M reported preliminary revenue was up for the fourth quarter and full year in 2014. According to its financial report, fourth quarter revenue is expected at $48.7 million to $49.3 million.
MiMedx reported full year revenue growth at around $117 million.
Nextremity Solutions appointed Nick A. Deeter CEO and chairman of the board of directors.
NuVasive full year 2014 revenue grew over 2013, and the revenue is expected to grow even higher in 2015. Full-year revenue in 2014 reached around $761 million, an 11 percent growth over the same period last year.
Also, NuVasive COO Keith Valentine will leave NuVasive, effective April 30; and Matt Link, who is currently executive vice president of U.S. Sales, will serve as president of U.S. sales and services.
OMNIlife science appointed Steven Nunes to vice president of market development.
After a year of delaying financial reports, Orthofix released expectations for the 2014 net sales, which are reported at $397 million to $401 million.
Silver Bullet Therapeutics announced that the U.S Patent and Trademark Office issued a patent for the release of antimicrobial metal ions to prevent infection that protects its cannulated bone screw.
Preliminary financial results show Stryker's net sales for the fourth quarter and full year grew significantly, but stock price growth was still below Wall Street's expectations, as the company experienced a negative per-share impact of $0.06.
Valorem Surgical received U.S. Food and Drug Administration clearance for the MaxiMIS Spinal Fixation System and announced the first case using the system has been performed.
Wright Medical Group expects 2014 sales to increase 23 percent to $298 million, according to the company's preliminary fourth quarter and full year financial report.
More articles on devices:
ECA Medical's disposable spinal system gets FDA clearance — 5 things to know
10 key trends in the global arthroscopic devices market
Nextremity Solutions appoints Nick Deeter CEO